Holen Sie sich die Stockscreener-App
5.58
3.12%
-0.18
Handel nachbörslich:
5.75
0.17
+3.05%
Schlusskurs vom Vortag:
$5.76
Offen:
$5.72
24-Stunden-Volumen:
19,270
Relative Volume:
0.88
Marktkapitalisierung:
$10.71M
Einnahmen:
$4.17M
Nettoeinkommen (Verlust:
$-50.71M
KGV:
-0.4141
EPS:
-13.474
Netto-Cashflow:
$-51.40M
1W Leistung:
-10.58%
1M Leistung:
+5.08%
6M Leistung:
-21.07%
1J Leistung:
-57.63%
1-Tages-Spanne:
$5.52
$5.904
1-Wochen-Bereich:
$5.52
$6.20
52-Wochen-Spanne:
$4.59
$13.80
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Firmenname
Bolt Biotherapeutics Inc
Sektor
Branche
Telefon
650-665-9295
Adresse
900 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie BOLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
5.58 | 11.06M | 4.17M | -50.71M | -51.40M | -13.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | Eingeleitet | Guggenheim | Buy |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Bolt Biotherapeutics Inc Aktie (BOLT) Neueste Nachrichten
How Bolt Biotherapeutics Inc. stock reacts to bond yieldsJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Is Bolt Biotherapeutics Inc. (6LP0) stock a good hedge against inflationWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Will Bolt Biotherapeutics Inc. stock reach Wall Street targetsOptions Play & Weekly Chart Analysis and Guides - newser.com
Risk adjusted return profile for Bolt Biotherapeutics Inc. analyzed2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
What dividend safety score for Bolt Biotherapeutics Inc. stock2025 Market WrapUp & Weekly High Return Stock Forecasts - newser.com
What MACD and RSI say about Bolt Biotherapeutics Inc.Weekly Profit Report & Weekly Breakout Opportunity Watchlist - newser.com
Why Bolt Biotherapeutics Inc. (6LP0) stock signals breakout potential2025 Top Gainers & Daily Volume Surge Signals - newser.com
Can Bolt Biotherapeutics Inc. rally from current levelsTrade Performance Summary & Verified High Yield Trade Plans - newser.com
Will Bolt Biotherapeutics Inc. (6LP0) stock attract long term capital inflowsEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
Is Bolt Biotherapeutics Inc. stock undervalued vs historical averages2025 Historical Comparison & AI Based Buy and Sell Signals - newser.com
How Bolt Biotherapeutics Inc. (6LP0) stock correlates with oil marketsJuly 2025 Summary & Low Drawdown Trading Strategies - newser.com
Building trade automation scripts for Bolt Biotherapeutics Inc.Trade Ideas & Daily Profit Maximizing Tips - newser.com
Does Bolt Biotherapeutics Inc. show high probability of reboundTrade Entry Summary & Stepwise Trade Execution Plans - newser.com
Is Bolt Biotherapeutics Inc. forming a reversal patternQuarterly Trade Summary & AI Powered Market Entry Ideas - newser.com
Developing predictive dashboards with Bolt Biotherapeutics Inc. data2025 Momentum Check & Technical Pattern Recognition Alerts - newser.com
Technical analysis overview for Bolt Biotherapeutics Inc. stockSell Signal & AI Powered Market Entry Strategies - newser.com
Real time scanner hits for Bolt Biotherapeutics Inc. explained2025 Short Interest & Community Consensus Picks - newser.com
Can Bolt Biotherapeutics' Step-Up Dosing Strategy For BDC-4182 Deliver In 2026? - RTTNews
Can Bolt Biotherapeutics Inc. (6LP0) stock test all time highsJuly 2025 Recap & Safe Capital Growth Stock Tips - newser.com
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):